A novel microfluidic system for 3D epidermis and full-thickness skin growth for nanoparticle safety assessment

dc.contributor.authorCosta, Samanta
dc.contributor.authorCarneiro, Ana Beatriz Machado
dc.contributor.authorLebre, Filipe
dc.contributor.authorMeneses, João
dc.contributor.authorAinda, Alar
dc.contributor.authorMoura, C.
dc.contributor.authorAlfaro-Moreno, Ernesto
dc.contributor.authorRibeiro, Ana Rosa Lopes Pereira
dc.date.accessioned2025-12-12T09:52:12Z
dc.date.issued2025-11-02
dc.description.abstractChronic skin exposure to nanoparticles (NPs) from air pollution, cosmetics, tattoo inks, and smart textiles is linked to adverse effects such as accelerated aging, dermatitis, eczema, and increased melanoma risk. However, the limited predictive power and physiological relevance of conventional in vitro models, combined with the absence of standardized protocols for assessing NP toxicity, remain a major challenge. To address these limitations, the development of skin-on-chip (SoC) systems provides a more physiologically relevant solution, surpassing the constraints of static skin cultures. Here, a novel SoC model with dynamic perfusion and a modular architecture suitable for epidermis-only (EoC) and full-thickness (FT) skin models isdeveloped. Under dynamic conditions, both models are metabolically active, exhibit enhanced barrier function, and display a morphology resembling native human skin. Exposure to titanium dioxide (TiO2) NPs led to a 32.4% decrease in barrier integrity, a 12.1% reduction in metabolic activity, a 2.9% increase in permeability, and histological evidence of tissue damage. These alterations are associated with an early moderate inflammatory response, as indicated by the upregulation of chemokines. Collectively, these findings demonstrate that the microfluidic device functions as a versatile toxicological tool, with the biological complexity of the FT SoC enhancing its sensitivity for nanotoxicology studies.eng
dc.description.sponsorshipEuropean Union’s H2020 project Sinfonia (N.857253) and project LEARN (N.101057510), by the project SbDToolBox (NORTE-01-0145-FEDER-000047) supported by Norte Portugal Regional Operational Programme (NORTE 2020) under the PORTUGAL 2020 Part- nership Agreement through the European Regional Development Fund, and by National Funds through the FCT – Fundação para a Ciência e Tecnologia, I.P. under the scope of the project 2023.04124.BDANA (https://doi.org/10.54499/2023.04124.BDANA) and in the framework of the Strategic Funding UID/04650/2025.
dc.distributioninternational
dc.identifier.articlenumbere02518
dc.identifier.doi10.1002/adhm.202502518
dc.identifier.eissn2192-2659
dc.identifier.issn2192-2640
dc.identifier.pmid41178289por
dc.identifier.urihttps://hdl.handle.net/1822/98547
dc.language.isoeng
dc.peerreviewedyes
dc.publisherWiley-VCH Verlag
dc.relationNORTE-01-0145-FEDER-000047
dc.relation2023.04124.BDANA
dc.relationUID/04650/2025
dc.relation.hasversionhttps://advanced.onlinelibrary.wiley.com/doi/10.1002/adhm.202502518
dc.rightsopenAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectmicrofluidics
dc.subjectnanotechnology
dc.subjectskin-on-chip
dc.subjecttitanium dioxide nanoparticles
dc.subjectmicrofluidicspor
dc.subjectnanotoxicologypor
dc.subject.fosCiências Naturais::Ciências Biológicas
dc.subject.jelI: Health, Education, and Welfare
dc.subject.odsSaúde de qualidade
dc.titleA novel microfluidic system for 3D epidermis and full-thickness skin growth for nanoparticle safety assessmenteng
dc.typearticle
dspace.entity.typePublication
oaire.citationIssue6por
oaire.citationVolume15por
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
sdum.journalAdvanced Healthcare Materials

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
Adv Healthcare Materials - 2025 - Costa - A Novel Microfluidic System for 3D Epidermis and Full‐Thickness Skin Growth for (1).pdf
Tamanho:
3.22 MB
Formato:
Adobe Portable Document Format